Webinars
Available On Demand
Ensuring that Patient Support Services (PSS) are inspired by the patient and accurately reflect their key areas of need is an important facet of a patient-centric approach. Come join Jennifer Parr, Partner and Head of Patient Services & Patient Centricity at Trinity and Clare Gora, Vice President & Head of Analytics Client Development at Trinity as they discuss designing optimized PSS from holistic, robust patient journeys that identify the critical patient pain points, gaps, unmet needs and moments of meaning.…
Watch Now
Webinars
Available On Demand
Assessing the impact of market events, advocacy, promotion and messaging is a key focus for Marketing and Brand leaders in life sciences. Stakeholder-perception tracking research is an often-overlooked strategic and tactical input as brands look to optimize their commercial performance. Come join Lara Lyeth, a Principal in Trinity’s Performance Tracking CoE, as she hosts a lively discussion on performance tracking with special guests Viplav Shukla, an Associate Director in Trinity’s Performance Tracking CoE, Monte Smith, a Managing Director in Trinity’s Brand &…
Watch Now
Blog
Published March 10, 2023
Executive summary
83 non-traditional Chinese medicines successfully entered the National Reimbursement Drug List (NRDL) for the first time. This is a >20% increase from the 2021 and 2020 NRDL updates, indicating the growing interest of both manufacturers and payers to ensure reimbursement for novel therapies in China.
The percentage of products achieving NRDL inclusion within one year of regulatory approval continues to increase steadily, from 24% in 2020 to 53% in the 2022 update, keeping up the strong momentum of…
Read Now
Webinars
Available On Demand
The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future.
Join Trinity Life Sciences’ MedTech and Evidence, Value, Access and Pricing experts as they explore what the future DTx reimbursement landscape might look like, drawing upon detailed first-hand…
Watch Now
Webinars
Available On Demand
Patient-level insights. Now.
Getting the right therapies to the right patients
Assessing competitive dynamics
Maximizing the value of patient level data with dynamic cohort design and visualization tools
Trinity Patient Flow is an integrated toolkit, built to enable self-serve patient analytics and liberate patient-level data. Any patient-level claims or EHR data can be leveraged–whether it’s internally managed, vendor accessed or pre-populated.
Come join us for a virtual demo and discussion, where Rajeev Rangachari, Head of Product Engineering, Kevin Francis, Partner,…
Watch Now
Webinars
Available On Demand
Developing and refining U.S. contract strategy and contract design is challenging. One of the most critical hurdles is evaluating the holistic direct and indirect impacts of contract decisions across multiple scenarios at speed and with precision. Achieving that comprehensive view drives clear guidance to pricing decision-makers and avoids costly mistakes. Join Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value, Access & Pricing (EVAP), John Greenaway—EVAP Partner and Jennifer Boyce—EVAP Engagement Manager as they discuss tips and Trinity’s best practices to…
Watch Now
Case Studies
Background
A global rare disease company was looking to improve targeting precision and support field team effectiveness
Traditional targeting was non-viable due to the small size of the patient populations, complex disease recognition and diagnosis, and restrictive therapy eligibility criteria
Attempts by a prior analytics partner to use rule-based alerts failed, and even after two years, no new patients had been identified
Given the small number of patients in each indication, every new start is high value, both for the…
Read Now
Blog
Published March 2, 2023
Meet Melissa Leonhauser:
Melissa has over 20 years of experience managing analytic solutions that support pharmaceutical brand teams. She has helped introduce and shape how pharmaceutical manufacturers use Real World Data to understand the patient journey and inform their decision making.
I’m not sure if ‘multi-experience engagements’ is just the newest buzz phrase, but I like it.
It’s similar to ‘omnichannel marketing’ but with a focus on the customer instead of your efforts, and I appreciate that nuance. Let’s break…
Read Now
Blog
Published February 27, 2023
Executive Summary:
The 2023 off-year Drug Price Revisions are the second implementation of the off-year re-pricing approach by the Japanese Ministry of Health, Labor and Welfare (MHLW) and are predicted to result in additional price cuts to 48% of listed products across multiple therapeutic areas.
Although the MHLW continues to maintain a stance of leveraging price revisions to achieve budget savings, other policies (i.e., expansion of Orphan Drug Designation and Price Maintenance Premium revisions) signal an intent to foster and…
Read Now
Webinars
Available On Demand
Healthcare data is complex, voluminous and ever-changing. It can tell you how to attract patients, inform how you look at physicians and signal when the best window is to target them. It can serve many purposes, several concurrently, across life sciences commercialization.
Consequently, a new frontier has emerged: one where leading life sciences companies have moved from discrete projects and workflows into living, related, connected data leveraged across functions and lifecycle stages.
Come join Clare Gora, Vice President and Head…
Watch Now
